EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily Q Member 3

Ensembl ID : ENSCDRG00005006010
Gene Symbol: KCNQ3
1 Cross references
193 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 5

Ensembl ID : ENSCDRG00005001529
Gene Symbol: KCNQ5
1 Cross references
200 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSCDRG00005006235
Gene Symbol: PSEN1
3 Cross references
202 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSCDRG00005004293
Gene Symbol: PSEN2
3 Cross references
205 Possible Orthologues:

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSCDRG00005014154
Gene Symbol: PSENEN
3 Cross references
185 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSCDRG00005000147
Gene Symbol: PGR
1 Cross references
194 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSCDRG00005001403
Gene Symbol: PTGDR
1 Cross references
118 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCDRG00005011427
Gene Symbol: PTGDR2
1 Cross references
205 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSCDRG00005014294
Gene Symbol: PTGER1
1 Cross references
237 Possible Orthologues:

Prostaglandin E Receptor 2

Ensembl ID : ENSCDRG00005001414
Gene Symbol: PTGER2
1 Cross references
244 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCDRG00005009342
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSCDRG00005016717
Gene Symbol: PTGER4
1 Cross references
275 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).